Are we ready for mutational directed treatment: addressing the genomic basis of myeloma
Gareth Morgan et al.
Antifungal prophylaxis in leukemia patients
Understanding the genetic risks of CLL
Updated analysis of Phase III trial of idelalisib combined with bendamustine and rituximab in CLL
What are the best molecular diagnostic techniques in CLL?